Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities

Area of Science:

• Genetics
• Metabolic Diseases
• Nephrology

Background:

• Hyperuricemia and gout frequently coexist with hypertension, obesity, chronic kidney disease, and type 2 diabetes.
• Understanding the genetic basis of these co-associations is crucial for effective management.

Purpose of the Study:

• To investigate the genetic underpinnings of the co-occurrence of hyperuricemia and its common comorbidities.
• To determine if shared genetic factors explain the association between serum urate and traits like serum creatinine, systolic blood pressure, blood glucose, and body mass index.

Main Methods:

• Utilized multivariate genetic models, specifically Bayesian whole-genome regression.
• Analyzed data from two independent family-based cohorts: the Framingham Heart Study (FHS) and the Hypertension Genetic Epidemiology Network (HyperGEN).
• Estimated genetic variance and covariance between serum urate, serum creatinine, systolic blood pressure (SBP), blood glucose, and body mass index (BMI).

Main Results:

• Replicated findings in both FHS and HyperGEN showed serum creatinine was genetically correlated only with serum urate.
• Body mass index (BMI) demonstrated genetic correlations with serum urate, SBP, and blood glucose.
• Environmental covariance was highest for trait pairs involving BMI.

Conclusions:

• Identified two distinct genetic modules underlying the comorbidities of hyperuricemia and gout.
• One module links hyperuricemia with chronic kidney disease (via creatinine), separate from metabolic traits.
• A second module associates hyperuricemia with metabolic syndrome components (BMI, SBP, glucose).
• This provides a quantitative genetic basis for the clustering of hyperuricemia comorbidities.